We also tested its treatment efficacies in 2 preclinical models of autoimmune uveitis using our CD6-humanized mice and a humanized model of GVHD using NOD/SCID IL-2 receptor γ–/– (NSG) mice. The gene discussed is CD6; the disease is graft versus host disease.